Recent Updates
Recently added Catalysts
SINT Positive Sentiment

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Key Takeaway: SINTX Technologies will present at the H.C. Wainwright 28th Annual Global Investment Conference from September 14-16, 2026. The company's executives will discuss advancements in the FDA-cleared SINAPTIC® Foot & Ankle Implant System and its proprietary silicon nitride technology. They aim to enhance commercial opportunities and support shareholder value.
Price reaction · baseline $1.63 (2026-09-04 close) · hit pre-market · clean, no other SINT news in the window
day 0 close
+6.7%
day 1 · peak
+11.7%
day 3
+10.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prestigious investment conference.
  • Presentation on FDA-cleared medical technology.
  • Focus on expanding commercial opportunities.
  • Engagement with investors through one-on-one meetings.

Full Press Release Details

SALT LAKE CITY, Utah, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company commercializing proprietary silicon nitride technologies across medical and other high-value applications, today announced that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September 14–16, 2026, at the Lotte New York Palace Hotel in New York City.
Gregg Honigblum, Chief Investment Officer, and Ryan Elmore, President of SINTX, will deliver a company presentation and participate in one-on-one meetings with investors throughout the conference. The presentation will highlight SINTX’s progress in commercializing its FDA-cleared SINAPTIC ® Foot & Ankle Implant System, expanding adoption of its proprietary silicon nitride technology, growing its contract manufacturing activities, and advancing strategic initiatives designed to broaden the Company’s commercial opportunities and support long-term shareholder value.
Event Details Conference: 28th Annual H.C. Wainwright Global Investment Conference Date: September 14–16, 2026 Location: Lotte New York Palace Hotel, New York City
Investors interested in scheduling a one-on-one meeting with SINTX management are encouraged to contact their H.C. Wainwright representative, email meetings@hcwco.com , or contact SINTX Investor Relations at IR@sintx.com .
About SINTX Technologies, Inc.
Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics and biomaterials company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX’s technologies are supported by peer-reviewed research, a patent portfolio, U.S.-based manufacturing capabilities, and strategic industry relationships. The Company’s business includes proprietary biomaterials and medical device technologies, as well as contract manufacturing and other advanced ceramics opportunities. SINTX’s product portfolio includes the FDA-cleared SINAPTIC ® Foot & Ankle Implant System for reconstructive surgery.

Frequently Asked Questions

When is the H.C. Wainwright Conference?

The conference is scheduled for September 14-16, 2026.

What will SINTX present at the conference?

SINTX will present its FDA-cleared SINAPTIC® Foot & Ankle Implant System.

Who will represent SINTX at the conference?

Gregg Honigblum and Ryan Elmore will represent SINTX.

How can investors meet with SINTX management?

Investors can schedule meetings through their H.C. Wainwright representative.

Last updated: Sep 8, 2026